| Literature DB >> 19640265 |
Midori Shimizu1, Hitoshi Tainaka, Taro Oba, Keisuke Mizuo, Masakazu Umezawa, Ken Takeda.
Abstract
BACKGROUND: Nanotechnology is developing rapidly throughout the world and the production of novel man-made nanoparticles is increasing, it is therefore of concern that nanomaterials have the potential to affect human health. The purpose of this study was to investigate the effects of maternal exposure to nano-sized anatase titanium dioxide (TiO2) on gene expression in the brain during the developmental period using cDNA microarray analysis combined with Gene Ontology (GO) and Medical Subject Headings (MeSH) terms information.Entities:
Year: 2009 PMID: 19640265 PMCID: PMC2726979 DOI: 10.1186/1743-8977-6-20
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
List of GO terms selected for gene annotation
| Category | GO term | |
| biological process | developmental process | brain development |
| forebrain development | ||
| midbrain development | ||
| hindbrain development | ||
| generation of neurons | ||
| glial cell differentiation | ||
| biological regulation | cell death | |
| apoptosis | ||
| neuron apoptosis | ||
| activated T cell apoptosis | ||
| B cell apoptosis | ||
| negative regulation of neuron apoptosis | ||
| apoptotic mitochondrial changes | ||
| induction of programmed cell death | ||
| induction of apoptosis | ||
| anti-apoptosis | ||
| glucocorticoid biosynthesis | ||
| glucocorticoid metabolism | ||
| neurotransmitter metabolism | ||
| neurotransmitter transport | ||
| multicellular organismal process | cognition | |
| learning and, or memory | ||
| regulation of biological process | regulation of glial cell differentiation | |
| regulation of nerve growth factor receptor activity | ||
| regulation of glucocorticoid biosynthesis process | ||
| cellular process | mitochondrial fission | |
| mitochondrial fusion | ||
| response to stimulus | response to oxidative stress | |
| response to reactive oxygen species | ||
| response to superoxide | ||
| superoxide metabolism | ||
| glutathione biosynthesis | ||
| glutathione metabolism | ||
| molecular function | motor activity | |
| superoxide dismutase activity | ||
| glucocorticoids receptor activity | ||
| brain derived neurotrophic factor binding | ||
List of MeSH terms selected for gene annotation
| Category | MeSH term | |
| Anatomy | Blood Brain Barrier | Neurons |
| Microglia | Olfactory Receptor Neurons | |
| Mitochondria | Synapses | |
| Neuroglia | ||
| Diseases | Alzheimer Disease | Inflammation |
| Anxiety Disorders | Learning Disorders | |
| Attention Deficit Disorder | Memory Disorders | |
| with Hyperactivity | Mitochondrial Disease | |
| Autistic Disorder | Neurogenic Inflammation | |
| Cognition Disorders | Parkinson Disease | |
| Epilepsy | Schizophrenia | |
| Psychiatry and Psychology | Affective Symptoms | Memory |
| Anxiety | Memory, Short-Term | |
| Cognition | Motivation | |
| Depression | Stress, Psychological | |
| Emotions | ||
| Chemicals and Drugs | Apoptosis Inducing Factor | Anti-Anxiety Agents |
| Apoptosis Regulatory Proteins | Glutathione | |
| Caspases | Glutathione Peroxidase | |
| Brain Derived Neurotrophic | Glutathione Synthase | |
| Factor | Inflammation Mediators | |
| Glial Cell Line-Derived | Neuronal Apoptosis- | |
| Neurotrophic Factor | Inhibitory Protein | |
| Nerve Growth Factor | Nitric Oxide | |
| Hormones | Reactive Oxygen Species | |
| Glucocorticoids | Superoxides | |
| Growth Hormone | Superoxide Dismutase | |
| Thyroid Hormones | ||
| Neurotransmitters | Acetylcholine | Norepinephrine |
| Dopamine | Serotonin | |
| Epinephrine | Receptors, | |
| gamma-Aminobutyric Acid | Neurotransmitter | |
| Glutamic Acid | Neuropeptides | |
| Neurotransmitter Uptake | ||
| Inhibitors | ||
| Biological Science | Apoptosis | Motor Activity |
| Cell Death | Neural Plasticity | |
| Gene, Mitochondrial | Oxidative Stress | |
| Lipid Peroxides | ||
The number of genes differentially expressed in maternal TiO2 exposure group
| Age | Upregulated | Downregulated | Total |
| Embryonic day 16 | 229 | 233 | 462 |
| 2 days old | 234 | 630 | 864 |
| 7 days old | 351 | 66 | 417 |
| 14 days old | 450 | 288 | 738 |
| 21 days old | 613 | 1274 | 1887 |
Significantly enriched GO categories in maternal exposure group vs. control group
| GO term | Enrichment factor | P value |
| (None) | ||
| apoptosis | 1.04 | .05 |
| brain development | 1.21 | .04 |
| motor activity | 1.80 | .02 |
| apoptosis | 1.11 | .01 |
| glial cell differentiation | 5.14 | .02 |
| activated T cell apoptosis | 3.75 | .02 |
| brain development | 1.48 | .00 |
| cell death | 1.08 | .04 |
| induction of apoptosis | 1.28 | .01 |
| motor activity | 1.58 | .05 |
| response to oxidative stress | 1.70 | .01 |
| response to reactive oxygen species | 1.53 | .05 |
| superoxide dismutase activity | 2.22 | .01 |
| anti-apoptosis | 1.58 | .02 |
| cell death | 1.03 | .04 |
| glutathione biosynthesis | 1.62 | .04 |
| superoxide dismutase activity | 1.75 | .01 |
Figure 1Summary of the extracted terms with genes differentially expressed in the maternal TiO.